GCP consultant Donatella Ballerini explores how adherence to GCP influences site feasibility, shaping the success and credibility of a clinical trial.
- If Sponsors Invite Patients To See The Final Draft Protocol, It's Already Too Late
- FDA Finalizes Guidance On Dose Optimization For Oncology Therapies
- Why Are We Still Excluding Persons With Disabilities (PWDs) In Clinical Trials?
- Not What I Expected From A Vendor Conference
- Clinical Development Negotiation: How Can A Notebook, Chronodex, And Compendium Help Enhance Partnerships?
- Dedicated Trialist, Nurse Navigators Help Advance Cancer Therapy Into Accelerated Approval
- 4 Steps To Help Sponsors Return Individual Patient Data
GUEST COLUMNISTS
-
Dedicated Trialist, Nurse Navigators Help Advance Cancer Therapy Into Accelerated Approval
Thoracic medical oncologist Sally Lau, MD Lau discusses her role as a principal investigator, from the benefits of the FDA’s accelerated approval pathway to best practices for retaining a challenging patient population.
-
4 Steps To Help Sponsors Return Individual Patient Data
In part two of this series on individual patient data return (iPDR), Legacy Health Strategies experts offer four steps to help sponsors make iPDR a reality.
-
Returning Individual Trial Data To Patients: How And Why It Needs To Happen
Returning individual data to clinical trial participants is seen by many as "the right thing to do." Yet, its uptake is lacking. Legacy Health Strategies experts discuss why it's so important and how it can be achieved in part one of this two-part series.
-
Which Top HEOR Trends Will Have The Biggest Impact On Clinical Research?
ISPOR CEO Rob Abbott discusses Health Economics and Outcomes Research (HEOR) trends and how they're impacting clinical trials.
-
Pelage Embraces Diverse Patient Recruitment For Non-Hormonal Hair Loss Therapy
Pelage Pharmaceuticals’ CMO Qing Yu Christina Weng, MD discusses how the company expanded criteria to include patients of all skin and hair types and incorporate decentralized elements in their trial design for a novel hair loss treatment.
-
More Diverse Enrollment Means More Attention To I/E Language
Clinical research nurse Teri Crumb, MSN, RN, CCRC picks out a few potentially problematic inclusion/exclusion (I/E) criteria and details ways to address them.
-
3 Surefire Ways To Design Trials That Patients Want And Need
Alpha Tau Medical CMO Robert Den, MD details three ways sponsors can more effectively design clinical trials with patients in mind.
-
A 5-Step Approach To Strengthen Clinical Trial Partnerships In Low- And Middle-Income Countries
To find suppliers and partners for our clinical trial programs, we need to go beyond just selecting the best offer and then managing them. For virtual organizations in particular, we must strive to be the partner of choice.
CLINICAL TRIAL WHITE PAPERS
-
Accelerate Clinical Development With Patient-Centered Digital Endpoints
While biomarkers have improved trial efficiency in some cases, patient-centered clinical outcome assessments remain essential – the lack of which can lead to commercial catastrophe.
-
Navigating The Biotech Landscape Amidst Covid-19 And Beyond11/7/2023
Access comprehensive insights and analysis for a deeper understanding of the biotech landscape, including optimism and challenges felt throughout 2023 and what the future could hold.
-
Digital Endpoint Resource Guide: Obesity And Related Metabolic Disorders8/15/2024
Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.
-
Study Start-Up Challenges: Hard Realities, Effective Strategies3/13/2024
Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?
-
Mastering The Logistics Of Mobile Nurse Visits In Global Decentralized Clinical Trials7/12/2024
Efficient logistics planning is crucial for global DCTs. Explore strategies for managing mobile nurse visits, ensuring timely supply delivery, and navigating international regulations.
-
Precision Oncology Clinical Trials And Statistics 20243/12/2024
Delve into the latest advancements in clinical trials, targeted therapies, and the promising future of cancer care, uncovering innovative treatments shaping oncology.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Case Study: How Real-World Data Optimized An Oncology Clinical Trial Protocol7/23/2024
Many challenges in running clinical trials are difficult to prepare for, but some, such as trial enrollment and study operational execution, can be proactively addressed thanks to advances in high-quality RWD.
-
The Perfect Solution For Recruitment, Retention, And ROI8/15/2024
See how Citeline Connect was deployed to advance enrollment six months ahead of schedule for a sponsor’s Phase IV atopic dermatitis trial and build a community of engaged patients who can enroll in future studies.
-
Regulatory Portfolio Management: From Bad To Gold10/30/2023
Uncover how a multiphased approach helped a small biotech to organize its programs so that it could efficiently make decisions, timely adapt to changes in strategy, and better understand current activities.
-
Achieving Self Sufficiency In Data Collection For Optinose2/12/2024
Uncover how this specialty pharmaceutical company was able to gain control over its EDC environment by adopting a solution their team could use in-house.
-
Strategic Clinical Consulting Success Stories2/13/2024
Explore real-world examples of how the combination of strategic consulting, regulatory insights, and technical expertise can impact the development and approval process.
-
Study Completes Recruitment, Overcomes Pandemic Hurdles7/23/2024
Amid challenges during the COVID-19 pandemic, discover how recruitment was completed in three countries for a Sweden-based pharmaceutical company's phase 2b study.
NEWSLETTER ARCHIVE
- 09.19.24 -- FDA Under Pressure To Respond To China-Related Clinical Trials Questions
- 09.19.24 -- Accelerating Site Validation And Collaboration With AI And SIP Innovations
- 09.18.24 -- Remote Services And Technology Require More Regulatory Clarity For Investigators: A Call To Action
- 09.18.24 -- Patient-Led Designs And Optimized Solutions For Better Research Outcomes
- 09.17.24 -- Unlocking Next-Gen Clinical Trials With Data Sharing And Tech
CONTENT COLLECTIONS
FOCUS ON PATIENTS
-
Patient Co-Next's Pauline Frank discusses why pharma knows patient engagement is important but rarely succeeds in implementing it fully.
-
Consultant Kamila Novak dives into the importance of early patient input — and why sponsors have a hard time getting it (and implementing it).
-
Canary Advisors Cofounder and COO Richie Kahn details the National Council on Disability's call for the inclusion of people with disabilities in clinical trials.
RECRUITMENT AND DIVERSITY
-
Patient Co-Next's Pauline Frank discusses why pharma knows patient engagement is important but rarely succeeds in implementing it fully.
-
Consultant Kamila Novak dives into the importance of early patient input — and why sponsors have a hard time getting it (and implementing it).
-
Canary Advisors Cofounder and COO Richie Kahn details the National Council on Disability's call for the inclusion of people with disabilities in clinical trials.